ASP Isotopes(ASPI.US)

Company Encyclopedia
View More
name
ASP Isotopes
ASPI.US
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs.
448.78 B
ASPI.USMarket value -Rank by Market Cap -/-

Financial Score

31/12/2025 Update
C
Specialty ChemicalsIndustry
Industry Ranking28/47
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-187.23%E
    • Profit Margin-1259.21%E
    • Gross Margin8.65%E
  • Growth ScoreB
    • Revenue YoY147.78%A
    • Net Profit YoY-250.78%E
    • Total Assets YoY168.51%A
    • Net Assets YoY129.95%A
  • Cash ScoreB
    • Cash Flow Margin-7.94%D
    • OCF YoY147.78%A
  • Operating ScoreE
    • Turnover0.05E
  • Debt ScoreD
    • Gearing Ratio57.23%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    ASP Isotopes (NASDAQ:ASPI) Stock Price Down 5.3% Following Insider Selling

    ASP Isotopes (NASDAQ:ASPI) shares fell 5.3% to $5.4050 following insider selling by CFO Heather Kiessling, who sold 80,000 shares at $5.80. The stock's trading volume was down 70% from average levels. Analysts have mixed ratings, with Canaccord Genuity maintaining a "buy" and a $11.00 target, while Weiss Ratings issued a "sell". The company reported a quarterly loss of $0.15 EPS, missing estimates, and has a market cap of $602.42 million. Institutional investors hold 16.80% of the stock, with significant recent acquisitions noted.

    Market Beat·
    US
    ASPI
    -5.08%
    Market Beat·
    US
    ASPI
    -5.08%

    ASP Isotopes CFO Heather Kiessling Reports Sale of Common Shares

    Heather Kiessling, CFO of ASP Isotopes Inc., reported the sale of common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice. ASP Isotopes Inc. is responsible for the original content published via EDGAR on December 29, 2025.

    Reuters·
    US
    ASPI
    -5.08%
    Reuters·
    US
    ASPI
    -5.08%

    ASP Isotopes Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ASP Isotopes, Inc. - ASPI

    Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating ASP Isotopes, Inc. for potential breaches of fiduciary duties and violations of laws by its officers and directors. This follows accusations by Fuzzy Panda Research of misleading investors about its nuclear fuel technologies. A securities class action lawsuit against ASP Isotopes is ongoing, with the court allowing the case to proceed.

    MorningStar·
    US
    ASPI
    -5.08%
    MorningStar·
    US
    ASPI
    -5.08%

    903,103 Shares in ASP Isotopes Inc. $ASPI Purchased by Sara Bay Financial

    Sara Bay Financial acquired 903,103 shares of ASP Isotopes Inc., valued at $8,688,000, making it 2.4% of their portfolio. This purchase makes ASP Isotopes their 10th largest position. Institutional investors own 16.80% of the company's stock. Recent insider sales and analyst ratings are also noted, with a mixed outlook on the stock's performance.

    Market Beat·
    US
    ASPI
    -5.08%
    Market Beat·
    US
    ASPI
    -5.08%

    ASP Isotopes advances Renergen acquisition after compliance approval

    ASP Isotopes Inc. announced that South Africa's Takeover Regulation Panel approved its acquisition of Renergen Limited. Renergen shareholders will receive 0.09196 new ASP Isotopes shares per Renergen share. Key milestones include the suspension and termination of Renergen's listings and the listing of new ASP Isotopes shares. The acquisition marks a significant step in ASP Isotopes' expansion. Analysts rate ASPI stock as Hold with a $6.00 price target, noting financial and technical challenges but some positive momentum from recent events.

    Tip Ranks·
    US
    ASPI
    -5.08%
    Tip Ranks·
    US
    ASPI
    -5.08%
    © 2025 Longbridge｜Disclaimer